Recent Articles
XPeng Stock Will Be a Winner, but Let It Settle Down First
XPEV stock has more than doubled in a matter of weeks. The long-term opportunity is huge, but near-term trading might see some volatility.
Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19
Simply put, blockchain is the safest way to store and transfer information ever created, which makes it ideal for tracking vaccines.
MoneyLine Podcast: These Charts Explain Where You Should Be Investing …
Work-from-home stocks have been thriving during this time, but are there still good buys? On this episode of the Moneyline podcast, Matt shares one name to buy, one to avoid and one to watch.
The Selloff in Alteryx Stock Is a Gift for Long-Term Growth Investors
Alteryx has had a year of ups and downs, but that could prove to be an opportunity for investors to get in on AYX stock.
Volatility May Continue, But CRISPR Stock Remains a Buy
Even after rebounding in recent weeks, consider now (or any pullback) prime time to enter a long-term position in CRISPR stock.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
